ArticleEuropean journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology2025
Clinical analysis of Mycoplasma pneumoniae pneumonia combined with adenovirus infection in children with lobar pneumonia.
Article in European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- High-Dimensional Immune Profiling Reveals Innate-Adaptive Rebalancing and Subpopulation Trajectories in Pediatric SevereDiagnostics (Basel, Switzerland) · 2026Article
- Clinical characteristics and predictors of Mycoplasma pneumoniae pneumonia coinfection with Bordetella pertussis in children.Medicine · 2026Article
- Post-pandemic resurgence of Mycoplasma pneumoniae in coastal China: from seasonal waves to sustained transmission and expanded age susceptibility.BMC infectious diseases · 2026Article
- Immunopathogenesis, molecular phenotyping, and host-directed interventions for severe pediatricFrontiers in cellular and infection microbiology · 2026Review
- Building a diagnostic prediction model for severeFrontiers in public health · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
objectiveMycoplasma pneumoniae (MP) is a major pathogen that causes community-acquired pneumonia in children with a high rate of co-infection. Human adenovirus (HAdV) is a common co-infecting pathogen. This study aimed to analyze the clinical characteristics of children with lobar pneumonia caused by co-infection with MP and HAdV, and to investigate the correlation between the MP mutation sequence ratio (mutation depth/MP count) and HAdV sequence count with disease severity, thus providing evidence for clinical diagnosis and treatment.
methodsChildren with MP-infected lobar pneumonia hospitalized in the Department of Pediatric Respiratory Medicine at the First Hospital of Jilin University from September to November 2023 were enrolled in this study and divided into MP and MP + HAdV groups. Clinical manifestations, laboratory examinations, and treatments were compared between the two groups. Correlations of the MP mutation sequence ratio and HAdV sequence count with clinical manifestations, laboratory examinations, and treatments were analyzed.
resultsA total of 154 children with MP lobar pneumonia were included, with 96 cases in the MP group and 58 cases in the MP + HAdV group. The results showed that the MP + HAdV group had a longer total disease duration, fever duration, intravenous anti-MP drug administration duration, and systemic corticosteroid application duration, with a higher proportion of intravenous immunoglobulin use. The MP group had higher CRP levels and a higher incidence of pulmonary necrosis. After 10 days of treatment, the MP group showed better improvement in the pneumonia volume than the MP + HAdV group. There were no significant differences between the two groups in the length of hospital stay, peak fever, wheezing and rash, oxygen therapy proportion, or second-line anti-MP drug usage. No significant differences were observed between the two groups in the WBC, ESR, LDH, D-dimer, albumin, ALT, ferritin levels, incidence of atelectasis, pleural effusion, or bronchoscopy findings.
conclusionCo-infection with HAdV can exacerbate the condition of children with MP lobar pneumonia and increase treatment difficulty. Higher MP mutation sequence ratios are associated with more severe airway mucosal damage, and higher HAdV viral loads correlate with more severe disease.
Indexed as
Identifiers
40563048What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.